Satellite Symposia
Please continue to check this page for updates on the symposia being offered
2026 Satellite Symposia are industry-sponsored programs offered in conjunction with ASH specialty meetings. These events are offered in conjunction with the 2026 Highlights of ASH in Latin America and are not part of the official ASH meeting programming and are planned solely by the sponsoring company. There is no fee to attend, and they are open to all attendees.
Satellite Symposia Schedule:
*All symposia take place in the Grand Hyatt
| Date | Time | Room Name | Sponsoring Company | Topic | Speakers(s) |
| Friday, May 1 | 12:50 p.m. - 1:50 p.m. | Valle | AstraZeneca | Updates in Chronic Lymphocytic Leukemia Post-ASH 2025 | Dr. Augusto Miroli (Hospital Churruca-Visca, Argentina) |
| Friday, May 1 | 12:50 p.m. - 1:50 p.m. | Tolima | AMGEN | Current Role of Blinatumomab in First-Line Consolidation Phase in Ph- ALL in Columbia | Dr. Mónica Cabrero (University of Salamanca, Spain) Moderator: Dr. Mónica Arévalo Zambrano |
| Friday, May 1 | 12:50 p.m. - 1:50 p.m. | Nariño | Novartis | Evolution in CML management: from innovation to clinical impact | Dr. Carla Boquimpani (Brazil) Moderator: Jaime Fernando Valdés (Colombia) |
| Friday, May 1 | 5:50 p.m. - 6:50 p.m. | Valle | Eli Lilly | LLC: Are we ready for the next generation of BTK inhibitors | Dr. Kenny Galvez y el Dr. Guillermo Quintero. |
| Friday, May 1 | 5:50 p.m. - 6:50 p.m. | Tolima | Johnson & Johnson | Treatment sequencing in multiple myeloma | Dr. Breno Moreno de Gusmao |
| Saturday, May 2 | 12:35 p.m. - 1:35 p.m. | Valle | AstraZeneca | Post-ASH 2025 Evidence on BTK inhibitors in Mantle Cell Lymphoma | Dr. Augusto Miroli (Hospital Churruca-Visca, Argentina) |